Exam 3 Flashcards

1
Q

What does ADME stand for?

A

Absorption, Distribution, Metabolism, and Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three primary means to quantify drug effect?

A

Onset, duration and intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What goes on 1, 2, and 3?

A

1: Intensity
2: Duration
3. Onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens onset, intensity and duration on the red line in comparison to the black?

A

Onset: same, intensity: decreases, duration: increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Two reasons why less than 100% of a dose may reach the site of action

A

Degradation and excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The study of the absorption, distribution, biotransformation, and elimination of xenobiotics

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The study of the molecular, biochemical, and physiological effects of xenobiotics and their mechanisms of actions

A

pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The fate of a drug after it has entered the systemic circulation

A

drug disposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What three aspects make up pharmacotherapeutics?

A

pathophysiology, pharmacodynamics, and pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What was the greatest reason why drugs failed in Phase I of clinical trials in 1991? What was the %? What changed to lower the percentage (and what’s the %s value)?

A

Biggest reason: pharmacokinetics/bioavailability (40%)
Development of improved preclinical ADME greatly reduced drug attrition due to poor PK/bioavailability (<10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What route of administration has the most rapid onset? Slowest?

A

Fastest: IV slowest: smoked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the four routes of administration?

A

ingestion, inhalation, dermal, and parenteral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A reduction in the extent of absorption will impact which of the three measures of pharmacologic effect: onset, intensity, and/or duration?

A

Intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A reduction in the speed of entry into the systemic circulation will impact which of the three measures of pharmacologic effect: onset, intensity, and/or duration?

A

Onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Barriers and blood flow can impact both the speed and extent of ________ of a drug in the body

A

distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Of the four consequences of metabolism, what process is used for active to inactive metabolites?

A

phenobarbital -hydroxylation-> Hydroxyphenobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Of the four consequences of metabolism, what process is used for active to active metabolites

A

Procainamide -acetylation-> N-acetylprocainamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Of the four consequences of metabolism, what process is used for inactive to active metabolites

A

Codeine -demethylation-> morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Of the four consequences of metabolism, what process is used for active to reactive metabolites

A

Acetaminophen -> reactive metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A ______ in the extent of absorption will reduce the peak drug conc. and the time the drug conc. remains above the minimally effective conc.

A

reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A reduction in the speed of entry into the systemic circulation will (inc/dec) the time it takes for the drug conc. to reach the minimally effective conc. Which part of the curve will be most impacted?

A

increase; the onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What barrier can significantly reduce the amount of drug that enters the site of action?

A

tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The graph below shows the conc vs time curve for two formulations of a bupropion. Compared to “Budeprion XL” (green), the maximal intensity of the pharmacologic effect for “Wellbutrin XL (red)” would be expected to occur:
a. later
b. sooner
c. at the same time

A

a. later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What percent of drug currently fail in clinical trials due to problems with the ADME of the compounds?
A. ~40%
B. <10%
C. 25%

A

B. <10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which route of admin. would be expected to produce the most rapid onset of pharmacologic effect?
a. oral
b. dermal
c. subcutaneous
d. intravenous
e. intramuscular

A

d. intravenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Morphine is a metabolite of codeine and this metabolite is responsible for the analgesic effect when codeine is admind. In a patent who has a genetic defect such that they cannot metabolize codeine, the magnitude of pain relief would be expected to be (incr/decr/same) compared to normal pateints?

A

decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which route of admin. avoids the need to cross a biological membrane in order to reach the systemic circulation?

A

intravenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Which route of admin. avoids the need to cross a biological membrane in order to reach the CNS?

A

None

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What impact would a drug that speeds up stomach emptying (metoclopramide) have on the time to peak conc for acetaminophen?

A

The peak drug conc would be higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

In Fick’s equation, if the diffusion rate increases, what happens to the concentration?

A

Increases directly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

For a drug which undergoes passive diffusion, the rate of transport across the membrane should (incr/decr/same) as the concentration increases

A

increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What site in the GI tract is where most drug absorption occurs? Why?

A

Small intestine: covered in folds of Kercking with villi containing microvilli. This increases the surface area and transit time (~3-5hrs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

The passive movement of drug through lipid membranes

A

transcellular diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

The passive movement of drugs between cells via tight junctions.

A

paracellular diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

A carrier-mediated process that involves a transport protein which moves drug with a conc. gradient

A

facilitated diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

A carrier-mediated process that requires energy.

A

active transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What types of transport are passive? Carrier-mediated?

A

Passive: transcellular and paracellular
Carrier-mediated: facilitated and active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Which transports are driven or move with a concentration gradient?
A. Transcellular
B. Facilitated
C. Paracellular
D. Active Transport

A

trans and para driven and facilitated moved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

In a base solution, which pKa(><=)pH is favorable? Acid?

A

Base: pKa<pH favorable
Acid: pKa>pH favorable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

T or F: Gastrointestinal transit time does NOT influence the extent and rate of drug absorption

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What type of diffusion in saturable and subject to competitive drug-drug interactions?

A

passive

42
Q

Transporter that removes solute (drug) out of the cell, reducing the amount of drug that accumulates in certain tissues, such as the brain

A

Efflux transporters

43
Q

Slowing gastric emptying would be expected to have what effect on the absorption of a drug absorbed by passive diffusion?
a. it will take longer to achieve the peak conc.
b. the peak conc. will occur sooner
c. slowing gastric emptying will have no effect on the timing of the peak conc. of the drug

A

a. it will take longer to achieve the peak conc.

44
Q

Which of the following mechanisms moves drug down a conc gradient?
a. Paracellular diffusion
b. Transcellular diffusion
c. Facilitated diffusion
d. active transport
e a&b
f a, b, & c
g. All of the above

A

f. a, b, and c

45
Q

Co-admin of an inhibitor of the efflux protein p-glycoprotein (pgp) would be expected to have what effect on the oral absorption of a drug that is a substrate for pgp?
a. the inhibitor of pgp will increase the amt of drug absorbed
b. the inhibitor of pgp will decrease the amt of drug absorbed
c. the inhibitor of pgp will not change the amt of drug absorbed

A

a. the inhibitor of pgp will increase the amt of drug absorbed

46
Q

Which of the following modifications would be not expected to increase the transcellular permeability of a drug molecule?
a. Removing ionized groups
b. Decreasing lipophilicity
c. Reducing molecular size

A

b. Decreasing lipophilicity

47
Q

What type of cell movement is frequently used for nanoparticle drug delivery?

A

endocytosis

48
Q

A process by which a cell engulfs and internalizes a particle

A

endocytosis

49
Q

Describe the effect of drug distribution on the concentration vs time curve: When is the highest dose achieved? Profusion?

A

Highest dose is achieved right after drug is administered. Highly profuse tissue will distribute drug more rapidly.

50
Q

Differentiate between perfusion rate limited and permeability rate limited distribution of drug into tissues

A

Perfusion rate limited: little membrane barrier causing more rapid movement of molecules from blood to body tissues
Permeability rate limited: greater membrane barrier causing lower movement of molecules from blood to body tissues

51
Q

The movement of drug molecules across vascular endothelial cells and into tissue interstitial space

A

transvascular transport

52
Q

A transvascular transport process that is driven by pressure

A

convection

53
Q

A transvascular trasnport process that is driven by a concentration gradient

A

diffusion

54
Q

Will perfusion rate limited or permeability rate limited show slower tissue distribution?

A

Permeability

55
Q

What method of transvascular transport is likely to be important for monoclonal antibodies?

A

Convection

56
Q

Describe how differences in tissue pH may result in the trapping of ionizable drugs

A

When going from a higher pH to lower pH, the drug may be uncharged in the higher pH allowing it to be transported through the membrane then become charged in the lower pH, “trapping” it from crossing the membrane and allowing excretion

57
Q

Describe how plasma protein binding effects distribution and pharmacologic effect

A

Drugs bound to plasma proteins limit distribution in tissues since only free drug can cross endothelial membrane

58
Q

4 ways drug may gain access to the CNS

A

(Appropriate DDT)
*appropriate physiochemical properties
*Disruption of the blood brain barrier
*Direct admin into CNS (most common: spinal tap)
*Utilize an existing transporter

59
Q

How to choose the best meds for a pregnant woman

A

Free drug will pass through fetal liver, so we want a large molecule

60
Q

The conc of drug within a tissue due to pH difference that lead to ionization of the drug in the tissue environment

A

drug trapping

61
Q

The initial movement of drug from highly perfused tissues to poorly perfused tissues

A

redistribution

62
Q

What organ is called a “privileged site”? why?

A

Brain- it excludes many compounds from entering the CNS

63
Q

What efflux transporter is used in the CNS to prevent drugs from accumulating in the brain?

A

p-glycoprotein (pgp or MDR1)

64
Q

(Polar/Non-Polar) drugs do NOT usually cross the placenta

A

Polar- its the best choice for prego women

65
Q

T or F: A drug that is only distributed into vascular space will exhibit a monoexponential blood conc vs time curve after intravenous admin.

A

True

66
Q

Which of the following drugs is most likely to undergo transvascular transport via convection?
a. asprin (MW 180 g/mole)
b. cimetidine (MW 252 g/mole)
c. Vancomycin (MW 143 g/mole)
d. Idarucizumab (MW 48k Daltons)
e. a, b, c
f. none of the above

A

d. Idarucizumab (MW 48k Daltons)

67
Q

A decrease in the plasma protein binding of a drug would be expected to have what effect on the distribution of drug into tissue?
A. a decrease in protein binding will increase the amount of drug in tissue
B. A. a decrease in protein binding will decrease the amount of drug in tissue
A. a decrease in protein binding will not change the amount of drug in tissue

A

A. a decrease in protein binding will increase the amount of drug in tissue

68
Q

A change in the structure of a drug molecule such that it is no longer transported by pgp (MDR1) would be expected to have what effect on the CNS conc. of drug compared to the original drug?
A The new drug would have a lower conc. in the CNS
B The new drug would have a higher conc. in the CNS
C. A The new drug would have the same conc. in the CNS

A

B The new drug would have a higher conc. in the CNS

69
Q

The primary route drugs are excreted from the body

A

renal (kidney) and hepatic

70
Q

Identify the key process and anatomical location involved in renal excretion

A

Filtration: beginning (afferent)
Secretion: Proximal convoluted tubule (PCT)
Absorption: Loop of Henle
Biotransformation

71
Q

What is the relationship in glomerular filtration?

A
72
Q

What is the molecular size limit for glomerular filtration?

A

MW<5000

73
Q

Creatinine vs clearance relationship for a drug eliminated by filtration

A
74
Q

Elimination of which of the following drug molecular weight would be unaffected by renal disease?
A. ~15,000
B. 500
C. 10

A

A. 15,000

75
Q

Drugs that undergo ATC are…
A. susceptible to competitive interaction
B. exhibit stereoselective renal excretion
C. Unsaturable
D. Only A and B
E. All of the above

A

D. (C should be saturable)

76
Q

The active transport of drug from blood into the renal tubule, occurring primarily in the proximal tubule

A

Active tubular secretion (ATS)

77
Q

The movement of solute from inside the renal tubule back into the blood. Passive and driven by high conc. that occurs as a result of the large fraction of filtrate that is reabsorbed.

A

Tubular reabsorption

78
Q

The reabsorption of drug from the small intestine after drug has been excreted through the bile into the intestine

A

enterohepatic recirculation

79
Q

The process by which food stimulates release of bile, and drug contained therein, into the small intestine, followed by reabsorption of the drug.

A

dose dumping

80
Q

What is glomerular filtration largely influenced by?

A

Molecular size and plasma protein binding

81
Q

T of F: Most tubular reabsorption is driven by carrier-mediated diffusion

A

F: concentration gradient (passive)

82
Q

When (this type of reabsorption) occurs, the process is saturable.

A

carrier-mediated tubular reabsorption

83
Q

What are the two processes of hepatic elimination?

A

metabolism (biotransformation) and biliary excretion

84
Q

First or second pass effect: Blood draining the stomach and small intestine flowing into the portal vein, all absorbed drug passing through the liver before entering the rest of the body

A

First

85
Q

T or F: pgp secretes drug from the hepatocyte into bile

A

T

86
Q

What are the primary factors determining biliary secretion?

A

Molecular weight and polarity

87
Q

(Small/Large) polar molecules are mostly eliminated in the bile

A

Large

88
Q

Which of the following renal excretory processes for drugs is most likely subject to competitive drug-drug interactions?
a. filtration
b. tubular secretion
c. tubular reabsorption
d. b and c
e all of the above

A

b

89
Q

In examining the renal elimination of a series of chemically related compounds, as molecular weight increases the extent of filtration will (increase/decrease/not have an influence)

A

decrease

90
Q

If enterohepatic recirculation (EHR) increases, the half-life of a drug will (Increase/decrease/no effect)

A

increase

91
Q

For a drug that is eliminated solely by glomerular filtration, a decrease in plasma protein binding will result in an (incr/decr) in the renal elimination of the drug

A

increase

92
Q

Which of the following vitamins undergo bioactivation in the kidney?
a. Vit A
b. Vit B
c. Vit C
d. Vit D
e. Vit E

A

d. Vit D

93
Q

Half-life (t 1/2) is influenced by _______

A

metabolism

94
Q

What is the first organ exposed to compounds absorbed in the gut?

A

Liver

95
Q

Which phase (I or II) using chemical modification (biotransformation) including oxidation, hydroxylation, etc. to introduce new functional group or expose group

A

Phase I

96
Q

Which phase (I or II) conjugated the polar group with drug

A

Phase II

97
Q

Phase I reactions typically occur by (oxidation/reduction) and are catalyzed by (cypP450/NADPH/O2) utilizing (cypP450/NADPH/O2) and (cypP450/NADPH/O2)

A

Phase I reactions typically occur by oxidation and are catalyzed by cypP450 utilizing NADPH and O2

98
Q

CYP2D6*1A
Identify the allele, subfamily, family and individual gene

A

CYP2(Family)D(subfamily)6(individual gene)*1A(allele)

99
Q

The active site of CYP contains an ____-_____ cofactor

A

iron-heme

100
Q

Factors that determine binding strength in reversible inhibition

A

coordination, hydrophobic, and specific contacts